CDSCO UID IMP/IVD/2020/000861_de87e990dd1cf4ee1cc10bc45eddd7af_ce86b963476d5c4b890670a0a9d8d897Direct Bilirubin
- UID
- IMP/IVD/2020/000861_de87e990dd1cf4ee1cc10bc45eddd7af_ce86b963476d5c4b890670a0a9d8d897
- Device class
- Class B
- Brand name
- quantILab
- License holder
- Instrumentation Laboratory India Pvt Ltd
- Approving authority
- CDSCO
- Product information
- Direct Bilirubin assay is intended for the quantitative in vitro diagnostic determination of direct bilirubin in human serum and plasma using the ILab Chemistry Systems
Direct Bilirubin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000861_de87e990dd1cf4ee1cc10bc45eddd7af_ce86b963476d5c4b890670a0a9d8d897. This device is marketed under the brand name quantILab. The license holder is Instrumentation Laboratory India Pvt Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.